The monoclonal antibody Alz-50, used to reveal cytoskeletal changes in Alzheimer's disease, also reacts with somatostatinergic neurons in the normal human hypothalamus and adjoining areas

J.A.P. van de Nes, A.A. Sluiter, C.W. Pool, W. Kamphorst, R. Ravid, D.F. Swaab

Research output: Contribution to journal/periodicalArticleScientificpeer-review

68 Downloads (Pure)
Original languageEnglish
Pages (from-to)97-109
JournalBrain Research
Volume655
Publication statusPublished - 1994

Cite this